Nanotechnology for the Detection and Therapy of Stroke
暂无分享,去创建一个
[1] J. Jansen,et al. The use of micro- and nanospheres as functional components for bone tissue regeneration. , 2012, Tissue engineering. Part B, Reviews.
[2] D. S. Lee,et al. The use of pH-sensitive positively charged polymeric micelles for protein delivery. , 2012, Biomaterials.
[3] Z. Fei,et al. Up-regulation of Heme oxygenase-1 attenuates brain damage after cerebral ischemia via simultaneous inhibition of superoxide production and preservation of NO bioavailability , 2013, Experimental Neurology.
[4] Donald R McCrimmon,et al. Biocompatible nanoscale dispersion of single-walled carbon nanotubes minimizes in vivo pulmonary toxicity. , 2010, Nano letters.
[5] Drug targeting to the brain. , 2007, Annual review of pharmacology and toxicology.
[6] Sabina Passamonti,et al. Hemolytic effects of water-soluble fullerene derivatives. , 2004, Journal of medicinal chemistry.
[7] Formulation of nanoparticle-eluting stents by a cationic electrodeposition coating technology: efficient nano-drug delivery via bioabsorbable polymeric nanoparticle-eluting stents in porcine coronary arteries. , 2009, JACC. Cardiovascular interventions.
[8] Vasilis Ntziachristos,et al. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging , 2010, Particle and Fibre Toxicology.
[9] J. Provenzale,et al. Uses of Nanoparticles for Central Nervous System Imaging and Therapy , 2009, American Journal of Neuroradiology.
[10] M. Guanci,et al. Acute Ischemic Stroke Review , 2007, The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses.
[11] Alan D. Lopez,et al. Mortality by cause for eight regions of the world: Global Burden of Disease Study , 1997, The Lancet.
[12] Takuro Niidome,et al. PEG-modified gold nanorods with a stealth character for in vivo applications. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[13] Jean-Christophe Olivier,et al. Drug transport to brain with targeted nanoparticles , 2011, NeuroRX.
[14] N. Manabe,et al. Quantum Dot as a Drug Tracer In Vivo , 2006, IEEE Transactions on NanoBioscience.
[15] J. Grotta,et al. Therapeutic Time Window and Dose Dependence of Xenon Delivered via Echogenic Liposomes for Neuroprotection in Stroke , 2013, CNS neuroscience & therapeutics.
[16] Duccio Cavalieri,et al. Carbon nanotube scaffolds instruct human dendritic cells: modulating immune responses by contacts at the nanoscale. , 2013, Nano letters.
[17] C. Stremnitzer,et al. Interleukin-10: An Anti-Inflammatory Marker To Target Atherosclerotic Lesions via PEGylated Liposomes , 2012, Molecular pharmaceutics.
[18] M. Apuzzo,et al. Visualizing the future: enhancing neuroimaging with nanotechnology. , 2011, World neurosurgery.
[19] K. Al‐Jamal,et al. Therapeutics, imaging and toxicity of nanomaterials in the central nervous system. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[20] E. Vicaut,et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials , 2007, Lancet Neurology.
[21] Ralph Weissleder,et al. Detection of Vascular Adhesion Molecule-1 Expression Using a Novel Multimodal Nanoparticle , 2005, Circulation research.
[22] M. Moskowitz,et al. Pathobiology of ischaemic stroke: an integrated view , 1999, Trends in Neurosciences.
[23] Minhyung Lee,et al. Amphiphilic peptides with arginines and valines for the delivery of plasmid DNA , 2011, Journal of cellular biochemistry.
[24] A. Rich,et al. Extensive neurite outgrowth and active synapse formation on self-assembling peptide scaffolds. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[25] A. Catafau,et al. Brain SPECT in clinical practice. Part I: perfusion. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[26] Minhyung Lee,et al. Dexamethasone-loaded peptide micelles for delivery of the heme oxygenase-1 gene to ischemic brain. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[27] Jain Kk. Nanodiagnostics: application of nanotechnology in molecular diagnostics , 2003 .
[28] T. Webster,et al. Nanotechnology and nanomaterials: Promises for improved tissue regeneration , 2009 .
[29] P. Cullis,et al. Interactions of liposomes and lipid-based carrier systems with blood proteins: Relation to clearance behaviour in vivo. , 1998, Advanced drug delivery reviews.
[30] U. Dirnagl,et al. Acute pathophysiological processes after ischaemic and traumatic brain injury. , 2010, Best practice & research. Clinical anaesthesiology.
[31] Jun Li,et al. High efficient electrical stimulation of hippocampal slices with vertically aligned carbon nanofiber microbrush array , 2009, Biomedical microdevices.
[32] D. Sackett,et al. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. , 1991, The New England journal of medicine.
[33] S. Andreescu,et al. Neuroprotective mechanisms of cerium oxide nanoparticles in a mouse hippocampal brain slice model of ischemia. , 2011, Free radical biology & medicine.
[34] Nicholas A Kotov,et al. Electrical stimulation of neural stem cells mediated by humanized carbon nanotube composite made with extracellular matrix protein. , 2009, Nano letters.
[35] Gregory W Albers,et al. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial , 2012, The Lancet.
[36] Francesca Ungaro,et al. Controlled drug delivery in tissue engineering. , 2008, Advanced drug delivery reviews.
[37] William D Rooney,et al. Superparamagnetic Iron Oxide Nanoparticles: Diagnostic Magnetic Resonance Imaging and Potential Therapeutic Applications in Neurooncology and Central Nervous System Inflammatory Pathologies, a Review , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[38] Leandro Provinciali,et al. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke , 1993 .
[39] Wei Xu,et al. Polymeric Micelles, a Promising Drug Delivery System to Enhance Bioavailability of Poorly Water-Soluble Drugs , 2013, Journal of drug delivery.
[40] H. Seton,et al. Magnetic CoPt nanoparticles as MRI contrast agent for transplanted neural stem cells detection. , 2011, Nanoscale.
[41] M. Abdelhalim. The effects of size and period of administration of gold nanoparticles on rheological parameters of blood plasma of rats over a wide range of shear rates: In vivo , 2011, Lipids in Health and Disease.
[42] Samuel I Stupp,et al. Heparin binding nanostructures to promote growth of blood vessels. , 2006, Nano letters.
[43] X. Wu,et al. Nanotechnological advances for the delivery of CNS therapeutics. , 2012, Advanced drug delivery reviews.
[44] T. Porter,et al. Ultrasound, microbubbles, and thrombolysis. , 2001, Progress in cardiovascular diseases.
[45] M. McPherson,et al. Recombinant self-assembling peptides as biomaterials for tissue engineering , 2010, Biomaterials.
[46] N. Kotov,et al. Successful differentiation of mouse neural stem cells on layer-by-layer assembled single-walled carbon nanotube composite. , 2007, Nano letters.
[47] S. Caruthers,et al. Molecular imaging of angiogenic therapy in peripheral vascular disease with ανβ3‐integrin‐targeted nanoparticles , 2010, Magnetic resonance in medicine.
[48] Mauro Ferrari,et al. Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases. , 2010, Trends in pharmacological sciences.
[49] Joseph P. Broderick,et al. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .
[50] H. Kusuhara,et al. Efflux transport systems for drugs at the blood-brain barrier and blood-cerebrospinal fluid barrier (Part 1). , 2001, Drug discovery today.
[51] S. Hunt,et al. Inhibition of inflammation and hyperalgesia in NK-1 receptor knock-out mice , 2003, Neuroreport.
[52] Ji‐Xin Cheng,et al. Nanomedicine for treating spinal cord injury. , 2013, Nanoscale.
[53] U. Dirnagl,et al. Stroke-induced Immunodeficiency Promotes Spontaneous Bacterial Infections and Is Mediated by Sympathetic Activation Reversal by Poststroke T Helper Cell Type 1–like Immunostimulation , 2003, The Journal of experimental medicine.
[54] Xinmai Yang,et al. Molecular photoacoustic tomography with colloidal nanobeacons. , 2009, Angewandte Chemie.
[55] K. Abe,et al. Neurological and pathological improvements of cerebral infarction in mice with platinum nanoparticles , 2011, Journal of neuroscience research.
[56] S. Feng,et al. Multimodal imaging for cancer detection. , 2010, Nanomedicine.
[57] Shuguang Zhang,et al. Emerging biological materials through molecular self-assembly. , 2002, Biotechnology advances.
[58] S. Bhatia,et al. Probing the Cytotoxicity Of Semiconductor Quantum Dots. , 2004, Nano letters.
[59] M. Prato,et al. Functional motor recovery from brain ischemic insult by carbon nanotube-mediated siRNA silencing , 2011, Proceedings of the National Academy of Sciences.
[60] M. Bryszewska,et al. Influence of PAMAM dendrimers on human red blood cells. , 2004, Bioelectrochemistry.
[61] K. Abe,et al. Strong neuroprotection with a novel platinum nanoparticle against ischemic stroke- and tissue plasminogen activator-related brain damages in mice , 2012, Neuroscience.
[62] I. Macrae,et al. Influence of Ischemia and Reperfusion on the Course of Brain Tissue Swelling and Blood–Brain Barrier Permeability in a Rodent Model of Transient Focal Cerebral Ischemia , 1997, Experimental Neurology.
[63] S. Yusuf,et al. The HOPE study and diabetes , 2000, The Lancet.
[64] Richard T. Lee,et al. Self-assembling short oligopeptides and the promotion of angiogenesis. , 2005, Biomaterials.
[65] Steven C Kazmierczak,et al. From diagnostics to therapy: prospects of quantum dots. , 2007, Clinical biochemistry.
[66] S. Stupp,et al. Tuning supramolecular mechanics to guide neuron development. , 2013, Biomaterials.
[67] M. Bally,et al. Liposomal drug delivery: recent patents and emerging opportunities. , 2007, Recent patents on drug delivery & formulation.
[68] Zahi A Fayad,et al. Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaques. , 2004, Journal of the American Chemical Society.
[69] Dzmitry G. Shcharbin,et al. Nanomaterials in stroke treatment: perspectives. , 2013, Stroke.
[70] Zahi A Fayad,et al. Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography , 2007, Nature Medicine.
[71] Young Ha Kim,et al. Brain-targeted delivery of protein using chitosan- and RVG peptide-conjugated, pluronic-based nano-carrier. , 2013, Biomaterials.
[72] Neil Desai,et al. Challenges in Development of Nanoparticle-Based Therapeutics , 2012, The AAPS Journal.
[73] Garry E. Kiefer,et al. Imaging of Vx‐2 rabbit tumors with ανβ3‐integrin‐targeted 111In nanoparticles , 2007 .
[74] Rohit Bakshi,et al. Neuroimaging of Stroke: A Review , 2003, Southern medical journal.
[75] K. Aoshiba,et al. Platinum nanoparticle antioxidants inhibit pulmonary inflammation in mice exposed to cigarette smoke. , 2009, Pulmonary pharmacology & therapeutics.
[76] Eileen Ingham,et al. Production of self-assembling biomaterials for tissue engineering , 2009, Trends in biotechnology.
[77] Tsong-Hai Lee,et al. Dexamethasone enhances upregulation of nerve growth factor mRNA expression in ischemic rat brain , 2005, Journal of Clinical Neuroscience.
[78] Byung-Soo Kim,et al. Stem cell recruitment and angiogenesis of neuropeptide substance P coupled with self-assembling peptide nanofiber in a mouse hind limb ischemia model. , 2013, Biomaterials.
[79] R. Simon,et al. Induction of Caspase-3-Like Protease May Mediate Delayed Neuronal Death in the Hippocampus after Transient Cerebral Ischemia , 1998, The Journal of Neuroscience.
[80] Parag Aggarwal,et al. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. , 2008, Molecular pharmaceutics.
[81] Jack Price,et al. The support of neural stem cells transplanted into stroke-induced brain cavities by PLGA particles. , 2009, Biomaterials.
[82] Vladimir P Torchilin,et al. PEG-based micelles as carriers of contrast agents for different imaging modalities. , 2002, Advanced drug delivery reviews.
[83] C Warlow,et al. Indications for early aspirin use in acute ischemic stroke : A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups. , 2000, Stroke.
[84] D. Clement. A randomised, blinded, trial of Clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996 .
[85] C. Antoniades,et al. Nanomedicine for the prevention, treatment and imaging of atherosclerosis. , 2012, Nanomedicine : nanotechnology, biology, and medicine.
[86] W. Banks,et al. Conjugates of superoxide dismutase 1 with amphiphilic poly(2-oxazoline) block copolymers for enhanced brain delivery: synthesis, characterization and evaluation in vitro and in vivo. , 2013, Molecular pharmaceutics.
[87] M. Meyyappan,et al. Vertically Aligned Carbon Nanofiber Architecture as a Multifunctional 3-D Neural Electrical Interface , 2007, IEEE Transactions on Biomedical Engineering.
[88] Kosuke Hamaguchi,et al. Intracellular Neural Recording with Pure Carbon Nanotube Probes , 2013, PloS one.
[89] H. Hong,et al. A new paradigm for stem cell therapy: Substance-P as a stem cell-stimulating agent , 2011, Archives of pharmacal research.
[90] Philippe Robert,et al. Recent advances in iron oxide nanocrystal technology for medical imaging. , 2006, Advanced drug delivery reviews.
[91] I. Tamai,et al. Transporter-mediated permeation of drugs across the blood-brain barrier. , 2000, Journal of pharmaceutical sciences.
[92] Marina A Dobrovolskaia,et al. Nanoparticles and the immune system. , 2010, Endocrinology.
[93] Jan P Stegemann,et al. Carbon nanotubes in neural interfacing applications , 2011, Journal of neural engineering.
[94] John H. Zhang,et al. Early inhibition of HIF-1α with small interfering RNA reduces ischemic–reperfused brain injury in rats , 2009, Neurobiology of Disease.
[95] T. Eckle,et al. Ischemia and reperfusion—from mechanism to translation , 2011, Nature Medicine.
[96] Samuel A. Wickline,et al. Endothelial &agr;&ngr;&bgr;3 Integrin–Targeted Fumagillin Nanoparticles Inhibit Angiogenesis in Atherosclerosis , 2006 .
[97] S. M. Robinson,et al. Polypeptide point modifications with fatty acid and amphiphilic block copolymers for enhanced brain delivery. , 2005, Bioconjugate chemistry.
[98] Shelton D Caruthers,et al. In Vitro Demonstration Using 19F Magnetic Resonance to Augment Molecular Imaging With Paramagnetic Perfluorocarbon Nanoparticles at 1.5 Tesla , 2006, Investigative radiology.
[99] Juewon Kim,et al. The effect of TAT conjugated platinum nanoparticles on lifespan in a nematode Caenorhabditis elegans model. , 2010, Biomaterials.
[100] A. R. Kulkarni,et al. Biodegradable polymeric nanoparticles as drug delivery devices. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[101] Saber M Hussain,et al. The interaction of manganese nanoparticles with PC-12 cells induces dopamine depletion. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[102] Jae Won Lee,et al. pH-responsive polymeric micelle based on PEG-poly(β-amino ester)/(amido amine) as intelligent vehicle for magnetic resonance imaging in detection of cerebral ischemic area. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[103] P. Wolf,et al. Depressive Symptoms and Risk of Stroke: The Framingham Study , 2007, Stroke.
[104] S. Nagahiro,et al. Edaravone, a Free Radical Scavenger, Inhibits MMP-9–Related Brain Hemorrhage in Rats Treated With Tissue Plasminogen Activator , 2009, Stroke.
[105] P. Chan,et al. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[106] J. West,et al. Nano-C60 cytotoxicity is due to lipid peroxidation. , 2005, Biomaterials.
[107] Samuel I Stupp,et al. Supramolecular nanostructures that mimic VEGF as a strategy for ischemic tissue repair , 2011, Proceedings of the National Academy of Sciences.
[108] Taro Shimizu,et al. PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[109] M. V. van Zandvoort,et al. Optical molecular imaging of atherosclerosis using nanoparticles: shedding new light on the darkness. , 2011, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[110] Xiaojun Zhao,et al. Designed amphiphilic peptide forms stable nanoweb, slowly releases encapsulated hydrophobic drug, and accelerates animal hemostasis , 2009, Proceedings of the National Academy of Sciences.
[111] W. Desmet,et al. Ultrasound thrombolysis in stent thrombosis , 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[112] M. McPherson,et al. Rational Molecular Design of Complementary Self-Assembling Peptide Hydrogels , 2012, Advanced healthcare materials.
[113] Greg M Thurber,et al. 18F labeled nanoparticles for in vivo PET-CT imaging. , 2009, Bioconjugate chemistry.
[114] David Schubert,et al. Cerium and yttrium oxide nanoparticles are neuroprotective. , 2006, Biochemical and biophysical research communications.
[115] T. Webster,et al. Carbon nanotubes impregnated with subventricular zone neural progenitor cells promotes recovery from stroke , 2012, International journal of nanomedicine.
[116] Nastassja A. Lewinski,et al. Cytotoxicity of nanoparticles. , 2008, Small.
[117] Ulrich Dirnagl,et al. Near-infrared fluorescence imaging with fluorescently labeled albumin: A novel method for non-invasive optical imaging of blood–brain barrier impairment after focal cerebral ischemia in mice , 2009, Journal of Neuroscience Methods.
[118] M. Stevens,et al. Novel materials for bone and cartilage regeneration. , 2006, Current opinion in chemical biology.
[119] P. Langhorne,et al. Do stroke units save lives? , 1993, The Lancet.
[120] Jangwook P. Jung,et al. A self-assembling peptide acting as an immune adjuvant , 2009, Proceedings of the National Academy of Sciences.
[121] C. K. Shen,et al. C(60) and water-soluble fullerene derivatives as antioxidants against radical-initiated lipid peroxidation. , 1999, Journal of medicinal chemistry.
[122] B. Siesjö,et al. Energy metabolism, ion homeostasis, and cell damage in the brain. , 1994, Biochemical Society transactions.
[123] Shuguang Zhang,et al. Designer self-assembling peptide nanofiber scaffolds for 3D tissue cell cultures. , 2005, Seminars in cancer biology.
[124] Juewon Kim,et al. Effects of TAT-conjugated platinum nanoparticles on lifespan of mitochondrial electron transport complex I-deficient Caenorhabditis elegans, nuo-1 , 2010, International journal of nanomedicine.
[125] Naomi J Halas,et al. Engineered nanomaterials for biophotonics applications: improving sensing, imaging, and therapeutics. , 2003, Annual review of biomedical engineering.
[126] D. Mozaffarian,et al. Heart disease and stroke statistics--2012 update: a report from the American Heart Association. , 2012, Circulation.
[127] N. Sims,et al. Mitochondria, oxidative metabolism and cell death in stroke. , 2010, Biochimica et biophysica acta.
[128] J. Saver. Time Is Brain—Quantified , 2006, Stroke.
[129] S. Gambhir,et al. Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics , 2005, Science.
[130] P. Wolf,et al. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.
[131] Beverly A Rzigalinski,et al. Treatment of Neurodegenerative Disorders with Radical Nanomedicine , 2007, Annals of the New York Academy of Sciences.
[132] P. Lipton,et al. Ischemic cell death in brain neurons. , 1999, Physiological reviews.
[133] K. Hynynen,et al. Enhanced delivery of gold nanoparticles with therapeutic potential into the brain using MRI-guided focused ultrasound. , 2012, Nanomedicine : nanotechnology, biology, and medicine.
[134] S. Ricci,et al. Sonothrombolysis for acute ischaemic stroke. , 2012, The Cochrane database of systematic reviews.
[135] Lauren M. Graham,et al. Experimental considerations on the cytotoxicity of nanoparticles. , 2011, Nanomedicine.
[136] A. Thrift,et al. Stroke Units, Tissue Plasminogen Activator, Aspirin and Neuroprotection: Which Stroke Intervention Could Provide the Greatest Community Benefit? , 2005, Cerebrovascular Diseases.
[137] A. Schroit,et al. In vivo recognition and clearance of red blood cells containing phosphatidylserine in their plasma membranes. , 1985, The Journal of biological chemistry.
[138] Michael G. Fehlings,et al. Self-Assembling Nanofibers Inhibit Glial Scar Formation and Promote Axon Elongation after Spinal Cord Injury , 2008, The Journal of Neuroscience.
[139] Shelton D Caruthers,et al. Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI , 2004, Magnetic resonance in medicine.
[140] M. Hennerici,et al. High-dose atorvastatin after stroke or transient ischemic attack. , 2006, The New England journal of medicine.
[141] M. Zakhary,et al. Oxidative stress in the context of acute cerebrovascular stroke. , 2000, Stroke.
[142] R K Jain,et al. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. , 1995, Cancer research.
[143] Krista L. Niece,et al. Selective Differentiation of Neural Progenitor Cells by High-Epitope Density Nanofibers , 2004, Science.
[144] Shelton D Caruthers,et al. Fluorine cardiovascular magnetic resonance angiography in vivo at 1.5 T with perfluorocarbon nanoparticle contrast agents. , 2007, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[145] Alok Dhawan,et al. Toxicity assessment of nanomaterials: methods and challenges , 2010, Analytical and bioanalytical chemistry.
[146] Fan Yang,et al. Robust cell migration and neuronal growth on pristine carbon nanotube sheets and yarns , 2007, Journal of biomaterials science. Polymer edition.
[147] Mary G. George,et al. An Updated Definition of Stroke for the 21st Century: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , 2013, Stroke.
[148] A. Kabanov,et al. Novel Nanomaterials for Clinical Neuroscience , 2008, Journal of Neuroimmune Pharmacology.
[149] T. Ishida,et al. Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes. , 2008, International journal of pharmaceutics.
[150] M. Moskowitz,et al. Synergistic effects of caspase inhibitors and MK‐801 in brain injury after transient focal cerebral ischaemia in mice , 1998, British journal of pharmacology.
[151] R. Daneman,et al. The blood–brain barrier in health and disease , 2012, Annals of neurology.
[152] M. Sasaki,et al. 11C-methionine uptake in cerebrovascular disease: A comparison with18F-FDG PET and99mTc-HMPAO SPECT , 2002, Annals of nuclear medicine.
[153] V. Labhasetwar,et al. Optical imaging to map blood-brain barrier leakage , 2013, Scientific Reports.
[154] Dennis E Discher,et al. Polymersome carriers: from self-assembly to siRNA and protein therapeutics. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[155] Konstantin Sokolov,et al. Plasmonic intravascular photoacoustic imaging for detection of macrophages in atherosclerotic plaques. , 2009, Nano letters.
[156] H. Hong,et al. A new role of substance P as an injury-inducible messenger for mobilization of CD29+ stromal-like cells , 2009, Nature Medicine.
[157] Maurizio Prato,et al. Asbestos-like pathogenicity of long carbon nanotubes alleviated by chemical functionalization. , 2013, Angewandte Chemie.
[158] V. Ona,et al. Minocycline Reduces Traumatic Brain Injury-mediated Caspase-1 Activation, Tissue Damage, and Neurological Dysfunction , 2001, Neurosurgery.
[159] Xiaojun Zhao,et al. Hemostatic efficacy of biological self-assembling peptide nanofibers in a rat kidney model. , 2010, Macromolecular bioscience.
[160] D. Harman. Free radical theory of aging. , 2003, Mutation research.
[161] Patrick Couvreur,et al. A Nanomedicine Transports a Peptide Caspase-3 Inhibitor across the Blood–Brain Barrier and Provides Neuroprotection , 2009, The Journal of Neuroscience.
[162] B. Davidson,et al. Transvascular delivery of small interfering RNA to the central nervous system , 2007, Nature.
[163] G. Ligresti,et al. Extracellular Matrix: A Matter of Life and Death , 2008, Connective tissue research.
[164] D D Allen,et al. Nanoparticle Technology for Drug Delivery Across the Blood-Brain Barrier , 2002, Drug development and industrial pharmacy.
[165] M. Moskowitz,et al. Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[166] G. Schneider,et al. Nano neuro knitting: peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[167] A. Kabanov,et al. Effect of Pluronic P85 on Amino Acid Transport in Bovine Brain Microvessel Endothelial Cells , 2009, Journal of Neuroimmune Pharmacology.
[168] Samuel A. Wickline,et al. Perfluorocarbon Nanoemulsions for Quantitative Molecular Imaging and Targeted Therapeutics , 2009, Annals of Biomedical Engineering.
[169] Z. Fayad,et al. Incorporation of an apoE-derived lipopeptide in high-density lipoprotein MRI contrast agents for enhanced imaging of macrophages in atherosclerosis. , 2008, Contrast media & molecular imaging.
[170] S. Stirdivant,et al. Evaluation of efficacy, biodistribution, and inflammation for a potent siRNA nanoparticle: effect of dexamethasone co-treatment. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[171] Kwok-Fai So,et al. Nano hemostat solution: immediate hemostasis at the nanoscale. , 2006, Nanomedicine : nanotechnology, biology, and medicine.
[172] Warren C W Chan,et al. Nanoparticle-mediated cellular response is size-dependent. , 2008, Nature nanotechnology.
[173] R. Whitby,et al. In Vitro Biocompatibility of Multiwalled Carbon Nanotubes with Sensory Neurons , 2013, Advanced healthcare materials.
[174] Ming Yan,et al. An in vitro study of vascular endothelial toxicity of CdTe quantum dots. , 2011, Toxicology.
[175] M A Horton,et al. The alpha v beta 3 integrin "vitronectin receptor". , 1997, The international journal of biochemistry & cell biology.
[176] Patrick Winter,et al. Nanomedicine Opportunities in Cardiology , 2006, Annals of the New York Academy of Sciences.
[177] R. Nitschke,et al. Quantum dots versus organic dyes as fluorescent labels , 2008, Nature Methods.
[178] J. Koistinaho,et al. Minocycline Provides Neuroprotection Against N-Methyl-d-aspartate Neurotoxicity by Inhibiting Microglia1 , 2001, The Journal of Immunology.
[179] G. Keren,et al. Effects of losartan + L-arginine on nitric oxide production, endothelial cell function, and hemodynamic variables in patients with heart failure secondary to coronary heart disease. , 2006, The American journal of cardiology.
[180] N. Noordhoek,et al. Contrast-Enhanced Angiographic Cone-Beam CT of Cerebrovascular Stents: Experimental Optimization and Clinical Application , 2010, American Journal of Neuroradiology.
[181] O. Salata,et al. Applications of nanoparticles in biology and medicine , 2004, Journal of nanobiotechnology.
[182] T Sakthivel,et al. DNA transfection and transfected cell viability using amphipathic asymmetric dendrimers. , 2000, International journal of pharmaceutics.